Harvard Bioscience (HBIO) Stock: Buy, Sell, or Hold?
HBIO - Harvard Bioscience Inc
$8.03
-0.12 (-1.47%)
▼
5d:
+0.37%
30d:
+30.15%
90d:
+20.93%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When HBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: HBIO shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: HBIO shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$8.77
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$5.44
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HBIO is currently trading at $8.03, which is considered extended relative to its 30-day fair value range of $6.55 to $8.02. From a valuation perspective, the stock is trading at a premium (Forward PE: 12.4) compared to its historical average (9.7). At these levels, the market is pricing in 8.7% annual earnings growth.
Technical Outlook: Technically, HBIO is in a uptrend. The price is currently testing key support at $7.85. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: HBIO scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HBIO is in a uptrend. The price is currently testing key support at $7.85. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: HBIO scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$6.55 -
$8.02
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
24.8%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (5/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($7.50)
- BULLISH: Expecting earnings turnaround to 8.7% growth with 11.1% revenue growth
- WARNING: Composite score 35/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$6.55 -
$8.02
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$7.85
Resistance Level
$8.40
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.45
Wall Street Target
$7.50
(-6.6%)
Revenue Growth (YoY)
11.1%
Earnings Growth (YoY)
-80.3%
Profit Margin
-11.9%
Valuation Premium vs History
+8.7% premium
PE vs Historical
12.5 vs 9.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+8.7%
(market-implied from PE analysis)
1-Year Target
$8.73
(+9%)
2-Year Target
$9.49
(+18%)
3-Year Target
$10.31
(+28%)
3-Yr Target (if PE normalizes)
(PE: 12→10)
PE COMPRESSION
$8.04
(+0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: September 12, 2026 3:04 AM ET
Data refreshes hourly during market hours. Next update: 4:04 AM
Data refreshes hourly during market hours. Next update: 4:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HBIO showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Stephen J Denelsky
BUY
10000 shares
2026-03-17
William Snider
BUY
8475 shares
2026-03-17
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 53 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$85 | 35 SELL |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$405 | 63 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$188 | 45 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$246 | 41 HOLD |
